Albert U, Rosso G, Maina G, Bogetto F. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord. 2008;105:297–303. https://doi.org/10.1016/j.jad.2007.05.020.

Article  PubMed  Google Scholar 

Baek JH, Ha K, Yatham LN, Chang JS, Ha TH, Jeon HJ, Hong KS, Chang SM, Ahn YM, Cho HS, Moon E, Cha B, Choi JE, Joo YH, Joo EJ, Lee SY, Park Y. Pattern of pharmacotherapy by episode types for patients with bipolar disorders and its concordance with treatment guidelines. J Clin Psychopharmacol. 2014;34:577–87. https://doi.org/10.1097/JCP.0000000000000175.

Article  PubMed  Google Scholar 

Baldessarini RJ. Chemotherapy in psychiatry: pharmacologic basis of treatments for major mental illness. 3rd ed. New York: Springer Press; 2013.

Book  Google Scholar 

Baldessarini RJ, Tondo L, Vázquez GH. Pharmacological treatment of adult bipolar disorder. Mol Psychiatry. 2019;24:198–217. https://doi.org/10.1038/s41380-018-0044-2.

Article  CAS  PubMed  Google Scholar 

Baldessarini RJ, Vázquez GH, Tondo L. Bipolar depression: a major unsolved challenge. Int J Bipolar Disord. 2020;8:1. https://doi.org/10.1186/s40345-019-0160-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153–60. https://doi.org/10.1136/ebmental-2019-300117.

Article  PubMed  PubMed Central  Google Scholar 

Barker TH, Migliavaca CB, Stein C, Colpani V, Falavigna M, Aromataris E, Munn Z. Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;21:189. https://doi.org/10.1186/s12874-021-01381-z.

Article  PubMed  PubMed Central  Google Scholar 

Bartoli F, Bassetti C, Gazzola M, Gianfelice L, Cavaleri D, Crocamo C, Carrà G. Prevalence and correlates of manic/hypomanic and depressive predominant polarity in bipolar disorder: systematic review and meta-analysis. Br J Psychiatry Open. 2024;10:e100. https://doi.org/10.1192/bjo.2024.51.

Article  Google Scholar 

Beunders AJM, Klaus F, Kok AAL, Schouws SNTM, Kupka RW, Blumberg HP, Briggs F, Eyler LT, Forester BP, Forlenza OV, Gildengers A, Jimenez E, Mulsant BH, Patrick RE, Rej S, Sajatovic M, Sarna K, Sutherland A, Yala J, Vieta E, Villa LM, Korten NCM, Dols A. Bipolar I and bipolar II subtypes in older age: results from the global aging and geriatric experiments in bipolar disorder (GAGE-BD) project. Bipolar Disord. 2023;25:43–55. https://doi.org/10.1111/bdi.13271.

Article  PubMed  Google Scholar 

Bourne C, Bilderbeck A, Drennan R, Atkinson L, Price J, Geddes JR, Goodwin GM. Verbal learning impairment in euthymic bipolar disorder: BDI v BDII. J Affect Disord. 2015;182:95–100. https://doi.org/10.1016/j.jad.2015.04.021.

Article  PubMed  PubMed Central  Google Scholar 

Brancati GE, Nunes A, Scott K, O’Donovan C, Cervantes P, Grof P, Alda M. Differential characteristics of bipolar I and II disorders: a retrospective, cross-sectional evaluation of clinical features, illness course, and response to treatment. Int J Bipolar Disord. 2023;11:25. https://doi.org/10.1186/s40345-023-00304-9.

Article  PubMed  PubMed Central  Google Scholar 

Demyttenaere K. The temporal experience in depression: from slowing down and delayed help seeking to the emergency setting and length of treatment. Int Rev Psychiatry. 2022;34:693–8. https://doi.org/10.1080/09540261.2022.2141103.

Article  PubMed  Google Scholar 

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88. https://doi.org/10.1016/0197-2456(86)90046-2.

Article  CAS  PubMed  Google Scholar 

Dittmann S, Hennig-Fast K, Gerber S, Seemüller F, Riedel M, Emanuel Severus W, Langosch J, Engel RR, Möller H-J, Grunze HC. Cognitive functioning in euthymic bipolar I and bipolar II patients. Bipolar Disord. 2008;10:877–87. https://doi.org/10.1111/j.1399-5618.2008.00640.x.

Article  PubMed  Google Scholar 

Doane MJ, Ogden K, Bessonova L, O’Sullivan AK, Tohen M. Real-world patterns of utilization and costs associated with second-generation oral antipsychotic medication for the treatment of bipolar disorder: a literature review. Neuropsychiatr Dis Treat. 2021;17:515–31. https://doi.org/10.2147/NDT.S280051.

Article  PubMed  PubMed Central  Google Scholar 

Faurholt-Jepsen M, Frost M, Busk J, Christensen EM, Bardram JE, Vinberg M, Kessing LV. Differences in mood instability in patients with bipolar disorder type I and II: a smartphone-based study. Int J Bipolar Disord. 2019;7:5. https://doi.org/10.1186/s40345-019-0141-4.

Article  PubMed  PubMed Central  Google Scholar 

Feng X-Z, Li Z, Li Z-Y, Wang K, Tan X, Zhao Y-Y, Mi W-F, Zhu W-L, Bao Y-P, Lu L, Li S-X. Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: a systematic review and meta-analysis. Psychiatry Res. 2024;332:115637. https://doi.org/10.1016/j.psychres.2023.115637.

Article  CAS  PubMed  Google Scholar 

Forte A, Baldessarini RJ, Tondo L, Vázquez GH, Pompili M, Girardi P. Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders. J Affect Disord. 2015;178:71–8. https://doi.org/10.1016/j.jad.2015.02.011.

Article  PubMed  Google Scholar 

Galling B, Garcia MA, Osuchukwu U, Hagi K, Correll CU. Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis. Expert Opin Drug Saf. 2015;14:1181–99. https://doi.org/10.1517/14740338.2015.1053457.

Article  CAS  PubMed  Google Scholar 

Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928.

Article  PubMed  PubMed Central  Google Scholar 

Joseph B, Nandakumar AL, Ahmed AT, Gopal N, Murad MH, Frye MA, Tobin WO, Singh B. Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis. Evid Based Ment Health. 2021;24:88–94. https://doi.org/10.1136/ebmental-2020-300207.

Article  PubMed  Google Scholar 

Karanti A, Kardell M, Joas E, Runeson B, Pålsson E, Landén M. Characteristics of bipolar I and II disorder: a study of 8766 individuals. Bipolar Disord. 2020;22:392–400. https://doi.org/10.1111/bdi.12867.

Article  PubMed  Google Scholar 

Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 2016;18:174–82. https://doi.org/10.1111/bdi.12371.

Article  CAS  PubMed  Google Scholar 

Kim AM, Salstein L, Goldberg JF. A systematic review of complex polypharmacy in bipolar disorder: prevalence, clinical features, adherence, and preliminary recommendations for practitioners. J Clin Psychiatry. 2021;82:20r13263. https://doi.org/10.4088/JCP.20r13263.

Article  PubMed  Google Scholar 

Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Mishima K, Iwata N. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Mol Psychiatry. 2021;26:4146–57. https://doi.org/10.1038/s41380-020-00946-6.

Article  CAS  PubMed  Google Scholar 

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis. Psychol Med. 2023;53:4064–82. https://doi.org/10.1017/S0033291722000745.

Article  PubMed  Google Scholar 

Koenders MA, Giltay EJ, Spijker AT, Hoencamp E, Spinhoven P, Elzinga BM. Stressful life events in bipolar I and II disorder: cause or consequence of mood symptoms? J Affect Disord. 2014;161:55–64. https://doi.org/10.1016/j.jad.2014.02.036.

Article  CAS  PubMed  Google Scholar 

Lam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, Blier P, Blumberger DM, Brietzke E, Chakrabarty T, Do A, Frey BN, Giacobbe P, Gratzer D, Grigoriadis S, Habert J, Ishrat Husain M, Ismail Z, McGirr A, McIntyre RS, Michalak EE, Müller DJ, Parikh SV, Quilty LS, Ravindran AV, Ravindran N, Renaud J, Rosenblat JD, Samaan Z, Saraf G, Schade K, Schaffer A, Sinyor M, Soares CN, Swainson J, Taylor VH, Tourjman SV, Uher R, van Ameringen M, Vazquez G, Vigod S, Voineskos D, Yatham LN, Milev RV. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l’humeur et de l’anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Can J Psychiatry. 2024;69:641–87. https://doi.org/10.1177/07067437241245384.

Article  PubMed  PubMed Central